MEDACTA GROUP N (MOVE) 133.0 CHF (-0.30%) | Healthcare & Biotech SIX Swiss Exchange

Medacta develops, manufactures and markets orthopedic implants and innovative surgical solutions for orthopedic and trauma surgery.

Momentum appears solid and constructive, with a favorable underlying trend despite a recent pause over the medium term. The stock continues to show stronger dynamics than a classic defensive healthcare name, reflecting market appeal for its specialization, innovation, and ability to deliver sustainable growth.

MEDACTA GROUP N

Trend Analysis of MEDACTA GROUP N

Want to see the full analysis?